| National Institutes of Health Office of Dietary Supplements | "A prospective, randomized trial limiting perioperative red blood cell transfusions in vascular patients" |
|---|---|
| "Effect of a liberal versus restrictive transfusion strategy on mortality in patients with moderate to severe head injury" | Bracey AW, Radovancevic R, Riggs SA; et al |
| Overview of the management and prognosis of sickle cell disease | : The McGraw-Hill Companies; 2016 |
|---|---|
| Pruthi RK expert opinion Mayo Clinic | FDA approves novel treatment to target abnormality in sickle cell disease |
Vincent JL, Baron JF, Reinhart K; et al.